JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| Tisagenlecleucel (chimeric antigen receptor T-cells targeting CD19) for patients with relapsed/refractory B-cell acute lymphoblastic leukemia: asystematic review and cost-utility analysis from a Spanish perspective | 349 |
Total Visits Per Month
| June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | |
|---|---|---|---|---|---|---|---|
| Tisagenlecleucel (chimeric antigen receptor T-cells targeting CD19) for patients with relapsed/refractory B-cell acute lymphoblastic leukemia: asystematic review and cost-utility analysis from a Spanish perspective | 7 | 0 | 5 | 26 | 0 | 3 | 0 |
File Visits
| Views | |
|---|---|
| Delgado_Tisagenlecleucel_MUESIOL.pdf | 150 |
Top country views
| Views | |
|---|---|
| United States | 139 |
| Spain | 55 |
| Germany | 20 |
| France | 9 |
| Switzerland | 6 |
| Saudi Arabia | 6 |
| Vietnam | 6 |
| United Arab Emirates | 5 |
| Brazil | 5 |
| Canada | 5 |
Top cities views
| Views | |
|---|---|
| San Ramon | 25 |
| Barcelona | 17 |
| Madrid | 13 |
| Redwood City | 12 |
| Boardman | 11 |
| Fremont | 9 |
| Ann Arbor | 8 |
| Hamburg | 7 |
| Mountain View | 6 |
| Ashburn | 5 |
Search DSpace
Browse
My Account
Statistics
